Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 6/2016

01-06-2016 | Letter

Effects of magnesium supplementation on the incidence of acute kidney injury in critically ill patients presenting with hypomagnesemia

Authors: Elisa Baldessar Barbosa, Cristiane Damiani Tomasi, Danusa de Castro Damasio, Marcelo Vinhas, Bruno Lichtenfels, Vanessa de Luca Francisco, Cassiana Mazon Fraga, Cristiane Ritter, Felipe Dal-Pizzol

Published in: Intensive Care Medicine | Issue 6/2016

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95:1–46CrossRefPubMed
2.
Alves SC, Tomasi CD, Constantino L, Giombelli V, Candal R, Bristot Mde L, Topanotti MF, Burdmann EA, Dal-Pizzol F, Fraga CM, Ritter C (2013) Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury. Nephrol Dial Transplant 28:910–916CrossRefPubMed
3.
Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN (2000) Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102:2353–2358CrossRefPubMed
4.
Firouzi A, Maadani M, Kiani R, Shakerian F, Sanati HR, Zahedmehr A, Nabavi S, Heidarali M (2015) Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention. Int Urol Nephrol 47:521–525CrossRefPubMed
5.
Walsh M, Srinathan SK, McAuley DF, Mrkobrada M, Levine O, Ribic C, Molnar AO, Dattani ND, Burke A, Guyatt G, Thabane L, Walter SD, Pogue J, Devereaux PJ (2014) The statistical significance of randomized controlled trial results is frequently fragile: a case for a fragility index. J Clin Epidemiol 67:622–628CrossRefPubMed
Metadata
Title
Effects of magnesium supplementation on the incidence of acute kidney injury in critically ill patients presenting with hypomagnesemia
Authors
Elisa Baldessar Barbosa
Cristiane Damiani Tomasi
Danusa de Castro Damasio
Marcelo Vinhas
Bruno Lichtenfels
Vanessa de Luca Francisco
Cassiana Mazon Fraga
Cristiane Ritter
Felipe Dal-Pizzol
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 6/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4276-9

Other articles of this Issue 6/2016

Intensive Care Medicine 6/2016 Go to the issue

Letter

Electrical impedance tomography to monitor lung sampling during broncho-alveolar lavage

Guidelines

Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals

Correspondence

Any trial can (almost) kill a good technique

Letter

Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients

Correspondence

Efficiency and safety of apnea test process under extracorporeal membrane oxygenation: the most effective method remains questionable

What's New in Intensive Care

What’s new in the diagnostic criteria of disseminated intravascular coagulation?